Cardiovascular Radiology: Page 265

Lack of ischemic mitral regurgitation on postop echo doesn't preclude additional problems
By Shalmali Pal
SAN FRANCISCO - When coronary bypass surgery is performed, ischemic mitral regurgitation (IMR) must be addressed as this complication is associated with poor long-term survival. But the durability of valve repair for IMR is currently under fire, despite its popularity over replacement procedures. Unfortunately, good postoperative echocardiography results cannot guarantee that the patient will not experience IMR, according to surgeons from Canada.
April 11, 2005
Boston Scientific initiates Syntax trial
By AuntMinnie.com staff writers
Interventional device manufacturer Boston Scientific said that enrollment has begun in the Syntax clinical trial, which will compare the performance of drug-eluting stents with cardiac surgery in patients with coronary artery disease.
April 11, 2005
Adding SPECT to women's workup improves coronary risk assessment
By Jerry Ingram
Women with an intermediate or high risk of developing coronary heart disease may benefit from SPECT myocardial perfusion imaging in addition to the standard exercise tolerance tests, according to research presented at the 2005 American College of Cardiology (ACC) meeting in Orlando.
April 11, 2005
Abbott gets FDA OK for ZoMaxx trial
By AuntMinnie.com staff writers
Interventional device developer Abbott Laboratories of Abbott Park, IL, said it has received conditional approval from the Food and Drug Administration for an investigational device exemption (IDE) application for the ZoMaxx drug-eluting stent.
April 6, 2005
Boston Scientific adds CE Mark
By AuntMinnie.com staff writers
Interventional device manufacturer Boston Scientific has received the European CE Mark for three large vessel sizes of its Taxus Express2 paclitaxel-eluting coronary stent system.
April 5, 2005
4D ultrasound shows promise for improving fetal echocardiography
By Erik L. Ridley
A 4D ultrasound technique can create "digital casts" of the fetal cardiac chambers and great vessels, opening the door for expanded detection of congenital heart disease, according to an article in the April issue of the Journal of Ultrasound in Medicine.
April 5, 2005
Boston Scientific gets FDA OK for Taxus in MRI
By AuntMinnie.com staff writers
Interventional device manufacturer Boston Scientific reported that the Food and Drug Administration has approved enhancements to the directions for use (DFU) of its Taxus Express2 paclitaxel-eluting coronary stent system, indicating that patients receiving the stent systems may safely undergo an MRI immediately following implantation.
April 4, 2005
Toshiba unveils Infinix-i software upgrades
By AuntMinnie.com staff writers
Multimodality developer Toshiba America Medical Systems has released software upgrades (version 3.5.1) for its Infinix-i series vascular and cardiac flat-panel detector (FPD) x-ray imaging system.
April 4, 2005
HeartLab expands archive offerings
By AuntMinnie.com staff writers
Cardiac image management firm Heartlab said it's increasing the capacity of its StoreSafe DVD archive using double-layer DVD technology from PowerFile of Santa Clara, CA.
April 3, 2005
Echo shows more left ventricular hypertrophy, predicts greater risk for Hispanics
By Jerry Ingram
An echocardiogram finding of increased left ventricular mass may portend even greater cardiovascular risk for Hispanics, according to a new study presented at the recent American College of Cardiology (ACC) meeting in Orlando, FL.
April 3, 2005
As cardiac CT interest heats up, so does EBCT, MDCT debate
By Kate Madden Yee
Cardiac imaging with multislice CT scanners is threatening to eclipse electron beam computed tomography, the technology that pioneered CT heart imaging. Although many believe that EBCT retains technical advantages over MDCT, practices are increasingly opting for the cheaper and more clinically versatile MDCT scanners -- raising questions about EBCT's future, according to this Technology Review article.
March 30, 2005
2002 03 13 15 53 59 706
Boston Scientific loses stent verdict
By AuntMinnie.com staff writers
Interventional device manufacturer Boston Scientific of Natick, MA, has lost a jury verdict in a patent infringement case with rival Johnson & Johnson of New Brunswick, NJ, over stent technology.
March 24, 2005
Previous Page
Page 265 of 326
Next Page